Pharmaceutical News

RSS
CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

CU Anschutz to train students to prescribe buprenorphine products for opioid use disorder

Anti-epileptic drugs linked to increase in patients' risk of suicide

Anti-epileptic drugs linked to increase in patients' risk of suicide

Statin use may reduce risk of developing lethal prostate cancer

Statin use may reduce risk of developing lethal prostate cancer

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New California law may expand use of HIV prevention drugs, with caveats

New California law may expand use of HIV prevention drugs, with caveats

New drug 'ubrogepant' may work for migraine

New drug 'ubrogepant' may work for migraine

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

Improving the efficiency of antiangiogenic and antifibrotic drug for treatment of lung cancer

Scientists develop new therapy for acute myeloid leukemia

Scientists develop new therapy for acute myeloid leukemia

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Researchers propose a novel method to underscore the benefits of HPV vaccine

Researchers propose a novel method to underscore the benefits of HPV vaccine

Cannabis cannot be used as a replacement drug for people with opioid use disorder

Cannabis cannot be used as a replacement drug for people with opioid use disorder

Antibiotics face an existential crisis

Antibiotics face an existential crisis

New CDC report raises concern over growing threat of antibiotic resistance

New CDC report raises concern over growing threat of antibiotic resistance

WHO announces two-year scheme to drive down the price of insulin

WHO announces two-year scheme to drive down the price of insulin

Opioid dose tapering rates as much as six times higher than recommended

Opioid dose tapering rates as much as six times higher than recommended

Study examines how drug promotion rules influence physician prescribing practices

Study examines how drug promotion rules influence physician prescribing practices

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

Regular co-use of pain and sleep medications may increase risk of frailty in older adults

New study highlights opportunities to optimize use of PrEP to prevent HIV among sex workers

New study highlights opportunities to optimize use of PrEP to prevent HIV among sex workers

Receiving multiple fracture-associated drugs may increase hip fracture risk

Receiving multiple fracture-associated drugs may increase hip fracture risk